髓样分化因子88在结直肠癌患者癌组织中的表达及其临床意义

doi:10.13481/j.1671-587x.20180529

Abstract

Abstract: Objective:To analyze the expressions of myeloid differentiation factor 88(MyD88) in cancer tissue and adjacent tissue of the patients with colorectal cancer and to explore the relationships between its expression and the clinicopathological parameters and the prognosis of the patients with colorectal cancer, and to clarify the clinical significance of MyD88 expression. Methods:A total of 90 cases of tumor tissue and adjacent tissue of the patients with colorectal cancer were collected and their clinical pathological materials were analyzed. The expressions of MyD88 in tumor tissue and adjacent tissue of the colorectal cancer patients were detected by immunohistochemistry. The expression levels of MyD88 in different tissues were analyzed by Image-Pro Plus 6.0 software. Kaplan-Meier method was used for survival analysis in the 90 patients with colorectal cancer. Results:The expression level of MyD88 in colorectal cancer tissue was significantly higher than that in adjacent colorectal cancer tissue(P<0.001). The MyD88 expression level had no correlations with the age, gender, tumor size and histologreal differentiation of the patients with colorectal cancer (P<0.05). The MyD88 expression level had correlations with the clinical stage, T stage, M stage and lymph node metastasis(P<0.05). The survival rate of the patients with colorectal cancer with higher expression of MyD88 was significantly lower than that of the patients with colorectal cancer with low expression of MyD88 (P<0.05). Conclusion:MyD88 is highly expressed in colorectal cancer tissue and it is associated with the clinical stage, T stage, M stage, and the situation of lymph node metastasis of the patients with colorectal cancer.

Key words: colorectal neoplasms, myeloid differentiation factor 88, lymph node metastasis, prognosis

CLC Number:

R735.37

ZHU Guangwei, ZHENG Wei, HUANG Yongjian, HUA Jin, YANG Shugang, YE Jianxin. Expression of MyD88 in cancer tissue of patients with colorectal cancer and clinical significance[J].Journal of Jilin University(Medicine Edition), 2018, 44(05): 1047-1051.

References

[1] Wu DM, Wang YJ, Han XR, et al. Tanshinone ⅡA prevents left ventricular remodelling via the TLR4/MyD88/NF-κB signalling pathway in rats with myocardial infarction[J]. J Cell Mol Med, 2018,5(10):3058-3072.
[2] Wang YL, Wang YL. MYD88 mutations and sensitivity to ibrutinib therapy[J]. J Mol Diagn, 2018, 20(2):264-266.
[3] Takeuchi O, Akira S. MyD88 as a bottle neck in Toll/IL-1 signaling[J]. Curr Top Microbiol Immunol, 2002, 270:155-167.
[4] 苏向前,张成海. 腹腔镜右半结肠癌CME根治术与策略[J]. 中华普外科手术学杂志:电子版,2017, 11(2):95-98.
[5] Echizen K, Oshima H, Nakayama M, et al. The inflammatory microenvironment that promotes gastrointestinal cancer development and invasion[J]. Adv Biol Regul, 2018,68:39-45.
[6] Sikora KA, Bennett JR, Vyncke L, et al. Germline gain-of-function myeloid differentiation primary response gene-88(MYD88) mutation in a child with severe arthritis[J]. J Allergy Clin Immunol, 2018, 141(5):1943-1947.
[7] Block MS, Vierkant RA, Rambau PF, et al. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer[J]. Mayo Clin Proc,2018, 93(3):307-320.
[8] Ma L, Feng L, Ding X, et al. Effect of TLR4 on the growth of SiHa human cervical cancer cells via the MyD88-TRAF6-TAK1 and NF-kappaB-cyclin D1-STAT3 signaling pathways[J]. Oncol Lett, 2018, 15(3):3965-3970.
[9] Wang EL, Qian ZR, Nakasono M, et al. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer[J]. Br J Cancer, 2010, 102(5):908-915.
[10] Arancibia SA, Beltrán CJ, Aguirre IM, et al. Toll-like receptors are key participants in innate immune responses[J]. Biol Res, 2007, 40(2):97-112.
[11] Sheedy FJ, O'Neill LA. The Troll in Toll:Mal and Tram as bridges for TLR2 and TLR4 signaling[J]. J Leukoc Biol, 2007, 82(2):196-203.
[12] Jin B, Sun T, Yu XH, et al. The effects of TLR activation on T-cell development and differentiation[J]. Clin Dev Immunol, 2012, 2012:836485.
[13] Kawai T, Akira S. TLR signaling[J]. Semin Immunol,2007, 19(1):24-32.
[14] An H, Qian C, Cao X. Regulation of Toll-like receptor signaling in the innate immunity[J]. Sci China Life Sci, 2010, 53(1):34-43.
[15] Zhou S, Wang G, Zhang W. Effect of TLR4/MyD88 signaling pathway on sepsis-associated acute respiratory distress syndrome in rats, via regulation of macrophage activation and inflammatory response[J]. Exp Ther Med, 2018, 15(4):3376-3384.
[16] 杜永生. MyD88在结直肠癌组织中的mRNA表达及DNA突变检测[D]. 昆明:昆明医科大学,2011.
[17] 秦艳,吴玉玉,白瑞珍, 等.结直肠腺瘤及结直肠癌中TLR7 TLR9及MyD88的表达[J]. 长治医学院学报,2013, 27(6):406-409.
[18] 于月红,钱雷,陈玮. 结直肠癌组织Toll样受体4和髓系分化蛋白88mRNA检测[J]. 海南医学,2011, 22(12):9-11.

Expression of MyD88 in cancer tissue of patients with colorectal cancer and clinical significance

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	ZHANG Tao, ZHANG Guoming, YAN Fei, LIU Zheng, HUO Qiang. Values of evaluation of heart rate variability in major adverse cardiac events in patients with acute myocardial infarction after PCI [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 780-785.
[2]	WANG Dan, LI Yifei, LI Chun, DONG Zhiheng, DONG Ying, GAI Xiaodong. Relationships between expressions of B7-H1 and B7-H4 and Foxp3⁺ regulated T-cell infiltration in colorectal cancer tissue [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 543-547.
[3]	YU Yunhe, DU Ye, HAN Bing, LI Sijie, SONG Lelian, FAN Zhimin. Observation on curative effects of neoadjuvant chemotherapy for different subtypes of Luminal B breast cancer and analysis on its prognosis [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 356-362.
[4]	FAN Liwen, FU Tong, GU Lin, WU Di, JIA Hongyao, SONG Dong. Accessory breast cancer: A case report and literature review [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 412-415.
[5]	JIAO Yang, YANG Dongye, YANG Jing, LIU Fei, KANG Xirong, ZHANG Jiansheng. Expressions of Krüppel-like factor 12 in cancer tissue and serum of patients with colorectal cancer and their significances [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1204-1208.
[6]	SUN Huiying, Du Bo, YU Zhi, LIU Hongquan, YU Hong. Clinical analysis on sudden sensorineural hearing loss complicated with BPPV and literature review [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 1025-1029.
[7]	SU Junyan, LI Yingjin, XU Changyan. Influence of CD96 and CD71 expressions in surface of leukemia stem cells in therapeutic effects and prognosis of children with acute leukemia [J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 776-781.
[8]	YANG Dongyang, LAI Xiaorong, LI Ying, MA Liyu, LUO Gang, LI Zijun, XU Fei, MA Dong. Influence of primary resection and KRAS gene mutation in prognosis of mild symptomatic patients with stage Ⅳ colorectal cancer [J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 805-811.
[9]	CHEN Zhihua, LIN Suyong, HAN Hongjing, SU Xiaobao, CHEN Shaoqin, DAI Qibao. Effects of KISS1 gene transfected by lentivirus on proliferation, invasion, and migration abilities of human colorectal cancer HCT116 cells [J]. Journal of Jilin University Medicine Edition, 2017, 43(03): 577-581.
[10]	ZHAO Zhiyan, SHENG Jindong, LIU Baoguo. Risk factors of malignant thyroid neoplasms and papillary thyroid cancer level Ⅵ lymph node metastasis [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 334-338.
[11]	HAO Zheng, LIU Nan, WANG Lu, LI Dongyuan, ZHAO Conghai, LIU Weiming, CHEN Zhuo, ZHANG Jinnan. Comparison of clinical effects between hematoma aspiration surgery guided by stereotactic and simple positioning in treatment of patients with medium dose of hypertensive hemorrhage [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 130-134.
[12]	ZHONG Hua, LIU Diqun. Expressions of COX-2 and Ki-67 in colorectal carcinoma tissue and theirclinical significances [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1168-1172.
[13]	LI Xingxing, TAN Jingjin, JIANG Shan, WAHG Ke. Role of let-7 and HMGA2 in occurrence and development of lung cancer: Meta-analysis [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1116-1125.
[14]	GU Sanwei, MA Hongshuang, ZHAO Ling, JIANG Zhenyu. Analysis on clinical characteristics of PM/DM combined with thyroid disease [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 999-1004.
[15]	DING Xianfei, ZHOU Xueliang, DOU Mengmeng, LI Lifeng, GUO Lina, WANG Feng, FAN Qingxia. Expression of mTOR and its relationship with prognosis of breast cancer: a Meta-analysis [J]. Journal of Jilin University Medicine Edition, 2016, 42(04): 783-788.